Nalbuphine

Chemical formula: C₂₁H₂₇NO₄  Molecular mass: 357.443 g/mol  PubChem compound: 5311304

Therapeutic indications

Nalbuphine is indicated for:

Moderate to severe pain, postoperative pain

Population group: only adults (18 years old or older)

Nalbuphine is indicated for the short-term relief of moderate to severe pain. It can also be used for pre- and post-operative analgesia.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Moderate to severe pain, postoperative pain

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Nalbuphine is indicated for the short-term relief of moderate to severe pain. It can also be used for pre- and post-operative analgesia.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Nalbuphine is contraindicated in the following cases:

Severe renal impairment

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Morphine, pethidine, dextromoramide, dihydrocodeine, dextropropoxyphene, methadone

at least one of
Morphine
Pethidine
Dextromoramide
Dihydrocodeine
Dextropropoxyphene
Methadone

Fentanyl

Fentanyl

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.